Hunan Warrant Pharmaceutical (688799.SH) subsidiary's chemical API terbutaline sulfate approved for marketing.

Hunan Warrant Pharmaceutical (688799.SH) announced that recently, its wholly-owned subsidiary Hunan Warrant Pharmaceutical Chiral Drug Co., Ltd. (referred to as "Chiral Drug") received the "Chemical API Marketing Application Approval Notification" for terbutaline sulfate issued by the National Medical Products Administration (notification number: 2026YS00963), and it has been published on the "Raw and Auxiliary Materials and Packaging Registration Information" platform of the Center for Drug Evaluation (CDE) of the National Medical Products Administration. Terbutaline sulfate is the API for preparations such as terbutaline sulfate nebulizer solution. Terbutaline sulfate nebulizer solution is mainly used to relieve bronchospasm associated with bronchial asthma, chronic bronchitis, emphysema, and other lung diseases.